1,652
Participants
Start Date
September 1, 2025
Primary Completion Date
September 30, 2031
Study Completion Date
January 1, 2040
acetylsalicyclic acid (ASA)
Daily dose 75 mg to 100 mg p.o.
Clopidogrel
Daily dose 75 mg p.o.
Rosuvastatin
"Daily dose 20 mg p.o. (10 mg once daily for the first 4 weeks, then 20 mg once daily for the remainder of the study period if tolerated).~If Rosuvastatin 20 mg is not tolerated, a dose reduction to 10 mg is allowed."
Atorvastatin
Daily dose 40 mg p.o. If Atorvastatin 40 mg is not tolerated, a dose reduction to 20 mg is allowed.
Rigshospitalet, Copenhagen
Bispebjerg og Frederiksberg Hospital, Copenhagen
Herlev Hospital, Herlev
Universitätsspital - Inselspital - University of Bern, Bern
Roskilde Hospital, Roskilde
Odense Universitetshospital, Odense
Kolding Hospital, Kolding
Regionshospitalet Gødstrup, Herning
Aarhus Universitetshospital, Aarhus
Aarhus University Hospital, Aarhus
Aalborg Universitetshospital, Aalborg
University Medical Center Hamburg-Eppendorf, Hamburg
Skånes Universitetssjukhus, Lund
Oslo University Hospital, Oslo
Rigshospitalet, Denmark
OTHER
Bispebjerg Hospital
OTHER
Herlev Hospital
OTHER
Zealand University Hospital
OTHER
Odense University Hospital
OTHER
Aalborg University Hospital
OTHER
Gødstrup Hospital
OTHER
Oslo University Hospital
OTHER
University Medical Center Hamburg-Eppendorf (UKE)
UNKNOWN
Insel Gruppe AG, University Hospital Bern
OTHER
Lund University Hospital
OTHER
Aarhus University Hospital
OTHER